A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Clinical trial NCT06038578 · RECRUITING
Trial details
- NCT number
- NCT06038578
- Sponsor
- Toray Industries, Inc
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-04
- Primary completion
- 2026-06-30
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.